ArticleslgStudy

chemistry

GYKI-52895

GYKI-52895 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand GYKI-52895 rather than just read about it. In short: GYKI-52895 is a drug which is a 2,3-benzodiazepine derivative that also shares the 3,4-methylenedioxyamphetamine pharmacophore. Unlike other similar drugs, GYKI 52895 is a selective dopamine reuptake inhibitor (DRI), which appears to have an atypical mode of action compared to other DRIs.

GYKI-52895 — main illustration
GYKI-52895 — illustration

Key takeaways

  • GYKI-52895 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect GYKI-52895 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of GYKI-52895 from memory before moving on to harder problems.

Reference excerpt

GYKI-52895 is a drug which is a 2,3-benzodiazepine derivative that also shares the 3,4-methylenedioxyamphetamine pharmacophore. Unlike other similar drugs, GYKI 52895 is a selective dopamine reuptake inhibitor (DRI), which appears to have an atypical mode of action compared to other DRIs. Its DRI activity is shared by numerous addictive drugs including amphetamine and its derivatives (e.g. dextromethamphetamine), cocaine, and methylphenidate and its derivatives (e.g. ethylphenidate). However, dopaminergic drugs are also prone to producing emetic effects such as in the case of apomorphine. Egis Pharmaceuticals began clinical development of the drug in 1997 for major depressive disorder and Parkinson's disease, but it was discontinued in 2001.

See also List of investigational Parkinson's disease drugs List of investigational antidepressants Talampanel GYKI 52466, another 2,3-benzodiazepine with other than GABAergic function Tifluadom Lufuradom Benzodiazepine Substituted methylenedioxyphenethylamine

References

Illustrations

GYKI-52895 illustration
GYKI-52895 illustration

Worked examples

Example 1 — a first encounter with GYKI-52895

Start with the simplest possible case. Write down what GYKI-52895 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to GYKI-52895 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about GYKI-52895 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of GYKI-52895

In research
GYKI-52895 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses GYKI-52895 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
GYKI-52895 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 4-Aminophenyl compounds, Abandoned drugs, Benzodiazepines, so understanding it makes those chapters shorter.
In everyday life
Look for GYKI-52895 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “GYKI-52895” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study GYKI-52895 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what GYKI-52895 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain GYKI-52895 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is GYKI-52895 in simple terms?

GYKI-52895 is a drug which is a 2,3-benzodiazepine derivative that also shares the 3,4-methylenedioxyamphetamine pharmacophore. Unlike other similar drugs, GYKI 52895 is a selective dopamine reuptake inhibitor (DRI), which appears to have an atypical mode of action compared to other DRIs.

Why does GYKI-52895 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study GYKI-52895?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on GYKI-52895.

Tags

  • 4-Aminophenyl compounds
  • Abandoned drugs
  • Benzodiazepines
  • Dopamine reuptake inhibitors
  • Methylenedioxyamphetamines

Keep exploring